UK markets closed

Regen BioPharma, Inc. (RGBP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5800-0.0300 (-4.91%)
At close: 03:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.51M
Enterprise value 3.13M
Trailing P/E 31.20
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.72
Price/book (mrq)N/A
Enterprise value/revenue 13.21
Enterprise value/EBITDA -3.80

Trading information

Stock price history

Beta (5Y monthly) 2.79
52-week change 3-59.34%
S&P500 52-week change 325.77%
52-week high 32.5500
52-week low 30.4010
50-day moving average 30.7258
200-day moving average 31.1922

Share statistics

Avg vol (3-month) 313.47k
Avg vol (10-day) 34.62k
Shares outstanding 54.11M
Implied shares outstanding 64.11M
Float 84.11M
% held by insiders 10.01%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1500
Last split date 306 Mar 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-171.12%

Management effectiveness

Return on assets (ttm)-84.06%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)236.56k
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-839.79k
Diluted EPS (ttm)-0.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)78.11k
Total cash per share (mrq)0.02
Total debt (mrq)693.77k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.02
Book value per share (mrq)-1.26

Cash flow statement

Operating cash flow (ttm)-482.07k
Levered free cash flow (ttm)-66.86k